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Results: In the following table.
*nt =non-typeable.
Conclusion: While PV7 serotypes have declined since
2000, in 2004 approximately 20% of the invasive isolates
from this study were from the seven vaccine types (4, 6B,
9 V, 14, 18C, 19F, 23F). In-patients and out-patients were
equally likely to carry PV7 serotypes. Serotype 19A was the
most common serotype in both in- and out-patients, which
is cause for concern as this serotype is often non-susceptible
to penicillin and erythromycin. In-patients were more likely
to carry non-typeable isolates, while equal percentages of
isolates from both groups were non-encapsulated. Contin-
ued monitoring of post-vaccine serotype trends will be vital
to the management of pneumococcal disease.
doi:10.1016/j.ijid.2010.02.480
77.005
Clinical and laboratory test follow up of patients with
severe leptospirosis, after hospital discharge
A. Spichler1, D. Athanazio2,∗, A.C. Seguro1
1 Emilio Ribas Hospital, São Paulo, Brazil
2 Federal University of Bahia, Salvador, BA, Brazil
Background: Although the acute phase disease is well
described in leptospirosis, few studies have focused on the
follow up after Hospital discharge. Thus, our knowledge is
still insufﬁcient on how frequent are some late complica-
tions or what is the rate of remission of laboratory markers
of disease such kidney function tests, platelet count or liver
enzymes. We investigated the frequency of clinical mani-
festations and the laboratory test abnormalities in patients
who had severe leptospirosis at the ambulatory care level,
after discharge.
Methods: Patients who had severe disease requiring inpa-
tient were asked to return to the reference Hospital Emilio
Ribas after discharge. The mean interval between Hospi-
tal discharge and the ambulatory visit was 24.7± 11.1 days
(mean± SD). Clinical and laboratory data were collected.
Results: Thirty-nine consecutive patients were enrolled.
Most patients were males (85%, 35/39) and the mean age
was 35.5± 17.6 years. The mean period of hospitalization
was 11.5± 7.0 days. During hospitalization, the patients
presented the following clinical manifestations or complica-
tions: pulmonary involvement (26%, 10/39), jaundice (59%,
23/39), renal failure (44%, 17/39, six requiring dialysis), and
shock (8%, 3/39). Twelve (31%) required ICU support. The
following abnormal laboratory test results were obtained in
the acute phase disease: serum creatinine > 3mg/dl (36%,
14/39), Bilirubin > 6mg/dl (41%, 16/39), platelet count <
70,000 units per mm3 (21%, 8/39), aspartate aminotrans-
ferase > 100 UI/L (29%, 9/31) and alanine aminotransferase
> 100 UI/L (26%, 8/31). At the ambulatory visit, only
minor complaints were reported: weakness (n = 7), headache
(n = 3), myalgia (n = 1) while jaundice persisted three cases.
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veitis was not detected. No patient had platelet count
ower than 150,000 units/mm3. No patient had serum creati-
ine > 3mg/dl or serum Bilirubin > 6mg/dl at the ambulatory
isit. Serum Alanine aminotransferase > 100 UI/L persisted
n two patients.
Conclusion: Our results conﬁrm the general concept that
eptospirosis usually resolves without long lasting effects.
urther studies are recommended to evaluate if elevation of
iver enzymes, a laboratory test abnormality already associ-
ted with poor prognosis in previous studies, improves in a
ower rate when compared to other manifestations.
oi:10.1016/j.ijid.2010.02.481
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.s., B. afzelii, B. garinii, B. spielmanii) in patients with
orreliosis in Eastern Poland
. Tokarska-Rodak1, H. Fota-Markowska1,∗, M.
ozioł—Montewka1, F. S´miechowicz1, B. Gajownik2, M.
rokop3, R. Modrzewska1
Medical University, Lublin, Poland
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Military Hospital, Lublin, Poland
Background: The most common Borrelia genospecies
nvolved in the etiology of Lyme disease in Eastern Europe
re: B. burgdorferi s.s., B. garinii, and B. afzelii. However,
he role of other genospecies including B. spielmanii has
lso been suggested. In view of a paucity of epidemiologic
ata concerning the role of B. spielmanii as the potential
ausative agent of Lyme disease in Poland, investigation
owards identiﬁcation of patients with serologic evidence
f infection caused by this Borrelia genospecies was under-
aken.
Methods: The study group comprised 41 patients from
astern Poland with borreliosis (age range: 19-65 yrs).
etection of IgG and IgM antibodies to B. burgdorferi s.l. was
erformed using test (Mikrogen) which included the follow-
ng antigens for IgM and IgG: OspC and p18 (B. burgdorferi
.s., B. afzelii, B. garinii, B. spielmanii), VlsE, p100, p58,
41, p39, and OspA.
Results: The results of the study indicate that the simul-
aneous presence of IgM antibodies against OspC protein
haracteristic of all four genospecies (B. burgdorferi s.s.,
. afzelii, B. garinii, and B. spielmanii) was detected in
6 patients with clinical manifestations of borreliosis. The
resence of IgM antibodies to OspC antigen of B. spielmanii
ccompanied by negative results for the presence of anti-
odies against antigens of the remaining genospecies was
etected in one patient.
The IgG antibodies against B. burgdorferi s.l. were
bserved with varying frequency:anti- VlsE in 22 patients,
anti-OspC for four genospecies: B. burgdorferi s.s., B.
afzelii, B. garinii and B. spielmanii in 9 patients,
anti-p18 for single genospecies, more often for B. afzelii
(4 patients) and B. spielmanii (5 patients).
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appropriate antibiotic for empiric therapy. Further studies
are necessary to further determine the risk of Bacillus cereus
infection.
doi:10.1016/j.ijid.2010.02.484388 14
Conclusion: The results of the study suggest the pos-
ibility of co-infections with several genospecies of B.
urgdorferi s.l. evidenced by the presence of IgM antibod-
es to OspC of B. burgdorferi s.s., B. afzelii, B. garinii, and
. spielmanii. The detection of antibodies directed against
peciﬁc B. spielmanii antigens suggests that this microorgan-
sm may be responsible for triggering borreliosis both as a
ingle etiologic agent and in co-infection with other Borrelia
enospecies.
oi:10.1016/j.ijid.2010.02.482
7.007
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Background: Enterococcal bone and joint infections
EBJI) are an uncommon disease and the optimal treatment
nd outcome have been poorly deﬁned. The objective was
o analize the outcome of EBJI episodes (ep.) according
o patients’ characteristics and microbiological features,
onsidering type of surgery implemented and antibiotic
reatment chosen.
Methods: We performed a retrospective cohort study of
atients with EBJI, treated by our working group from 1/91
o 3/09. Categorical variables are presented as percentages
nd continuous variables as median and interquartile range
IQR). Differences were considered statistically signiﬁcant
t p <= 0.05.
Results: We evaluated 35 EBJI ep. occurred in 34 patients
ccounting for 3.3% of all BJI (35/1071) seen in the period
onsidered. Median age 63 years old (range IQR 40-72), 63%
emale patients. Comorbidities (diabetes, peripheral vas-
ular disease, cancer) were found in 31.4%. Twenty eight
p. (80%) were implants associated infections (IAI) (15
rosthetic joint, 13 fractures with internal ﬁxation) and 7
20%) osteomyelitis (OM; 86% chronic). Five ep. (14.3%) had
olymicrobial cultures (4 P. aeruginosa, 1 MRSA). All patients
eceive antibiotic therapy (35 aminopenicillins, 5 glycopep-
ides, 1 carbapenems) during a median of 13 weeks (IQR
-24); 13 (37,1%) were treated with combined aminogly-
osides and 22 (62,8%) without them. Fifteen ep. (42,8%)
nderwent prolongued suppressive therapy for a median of
6 weeks (IQR 4-32). Surgery was performed in 19 ep. (67,8%)
f IAI (52,6% with debridement and retention of the implant)
nd 4 ep. (57,1%) of osteomyelitis. Follow up: 15 months
median; IQR 10-24). The overall outcome was favorable in
0 ep. (85,7%); there were 5 relapses (14,3%) and no failures.
sing an univariated analysis, we evaluated the outcome
ccording this variables: age, gender, comorbidities, micro-
iology, implant, surgery performed and its modality, use ofternational Congress on Infectious Diseases (ICID) Abstracts
minoglycosides and length of antibiotic treatment. None of
hem were related to a better or worse outcome.
Conclusion: EBJI are an uncommon disease mostly asso-
iated to implants. Treatment must include surgery and
ntibiotics. In our series, outcome was not modify by
atients’ caractheristics, presence of an implant, type of
urgery performed, lenght of antibiotic treatment and use
f combined therapy with aminoglycosides.
oi:10.1016/j.ijid.2010.02.483
7.008
acillus cereus bacteremia in hospital setting
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. Suganaga1, H. Oka1, S. Kinoshita2, M. Nakamura2, H.
oshida2, K. Iwata1
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Background: Since Bacillus cereus is rarely associated
ctual infections, single positive blood culture is often con-
idered as contamination. However, it can cause number
f nosocomial infections such as catheter-associated blood
tream infection. We investigated the bacteremic patients
o assess the clinical impact of this organism.
Methods:We performed a retrospective analysis of blood-
tream infections due to B. cereus at a tertiary care hospital
n Kobe, Japan from October 2008 to September 2009. Cases
ere identiﬁed via microbiology laboratory reports, and
elevant clinical data were collected from the electronic
edical record of each patient. The case with at least 2 set
ositive blood cultures were deﬁned as real infection.
Results: Nine cases of catheter related blood stream
nfections (CRBSI) caused by B. cereus were identiﬁed. Only
ne case had the presence of an indwelling central venous
atheter (CVC). Three cases (33%) were associated with
revious antibiotic therapy. Two cases (2/9, 22%) were asso-
iated with solid organ malignancies whereas no case with
ematological malignancy. One patient was on continuous
emodialysis. The most common characteristics (7/9, 77%)
ere the use of peripheral parenteral nutrition. These 7
ases had use of solutions containing 7.5% glucose and 3.0%
mino acid. For 8 cases vancomycin was used with success.
o patient died. All isolates were sensitive for vancomycin
hereas resistant to beta-lactams. Two isolates were sensi-
ive for clindamycin.
Conclusion: Bacillus cereus can cause CRBSI. Indwelling
VC may not increase Bacillus cereus CRBSI whereas
eripheral parenteral nutrition with higher amino acid
oncentration can be a risk factor. Vancomycin may be
